In addition, our results confirmed that the expression of c-FLIP was higher in KRASmut/P53mut condition, and the combination of bortezomib and PCC reduces anti-apoptotic protein c-FLIP by directly targeting bromo and extra terminal domain (BET) proteins and enhancing caspase-8-dependent apoptosis of cancer cells [13]. This evidence concerns the gene CFLAR and cancer.